Cipla Ltd KYS Report: Ownership & Insights

15:59 Dec 12

Cipla Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1517.40

+5.10 (+0.34%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Cipla Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Dec 12

1517.40

+5.10 (+0.34%)

62/100 High Financial Strength

Quality

42/100 Mid Valuation

Valuation

52/100 Technically Neutral

Technical

SWOT

Strength

Weakness

Opportunity

Threat

1.23L

Market Cap (Cr)

22.53

PE Ratio

3.72

Price to Book Ratio

49.51

RSI

19.13 %

Net Profit Margin

Rating Based on 8 Analysts

Buy 50%

Hold 50%

Sell 0%

Buy

The consensus recommendation from 4 analysts for Cipla Ltd. is Buy

Analyst Price Target

The average price target is 1704 with a high estimate of 1808 and low estimate of 1530

High Average Low

Current 1517.40

1808.00

1704.00

1530.00

Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password